Engineering and design software provider PTC (NASDAQ:PTC) will be reporting earnings tomorrow afternoon. Here’s what to ...

PTC Therapeutics (PTCT) saw its shares surge in the last session with trading volume being higher than average. The latest ...

PTC PTC underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) shot up 6.1% during trading on Monday after Cantor Fitzgerald raised their price target on the stock from $76.00 to $113.00. Cantor ...

Inc., a leading provider of software solutions for product design, manufacturing, and service, continues to navigate a challenging macroeconomic environment while positioning itself for future growth.

The case gained prominence after PTC News highlighted it, which led the child’s family members—his grandparents and uncle—to ...

Poonam Gupta will tie the knot on February 12 with assistant commandant, Avneesh Kumar currently posted in Jammu and Kashmir.

PTC Therapeutics, Inc. (NASDAQ:PTCT), a biopharmaceutical company focused on developing and commercializing novel medicines for rare disorders, finds itself at a critical juncture. With a promising ...

Barclays analyst Saket Kalia maintained a Buy rating on PTC (PTC – Research Report) today and set a price target of $215.00. The company’s ...

The stock's fall snapped a two-day winning streak.

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...

One of the top advanced manufacturing and material technology companies, PTC Industries, has inked a Memorandum of ...